Standout Papers

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors 2021 2026 2022 2024206
  1. A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors (2021)
    Jia Zhou, Camille Gelot et al. Nature Cancer

Immediate Impact

8 by Nobel laureates 5 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Rapid single-particle chemical imaging of nanoplastics by SRS microscopy
2024 Standout
3 intermediate papers

Works of Aleem Syed being referenced

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
2021 Standout
Raman Imaging in Cell Membranes, Lipid-Rich Organelles, and Lipid Bilayers
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Aleem Syed 638 242 433 26 1.2k
Robert P. Hammer 860 207 287 34 1.5k
Matthew S. Tremblay 554 192 339 28 1.7k
Tetsuya Kadonosono 627 203 126 51 1.1k
Atom Sarkar 674 257 112 35 1.4k
George Striker 626 137 201 24 1.2k
Marcelo Salierno 342 121 307 26 1.0k
Sharon Bloch 502 137 247 32 1.4k
Ying‐Xin Fan 1033 147 157 28 1.5k
Damien Alcor 697 52 201 17 1.2k
Rosaria P. Haugland 808 71 226 20 1.5k

All Works

Loading papers...

Rankless by CCL
2026